2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity
Authors
Keywords
Hydroxamic acids, Crystals, Histones, Apoptosis, Cell cycle and cell division, Enzyme inhibitors, Enzyme purification, Epigenetics
Journal
PLoS One
Volume 10, Issue 12, Pages e0134556
Publisher
Public Library of Science (PLoS)
Online
2015-12-24
DOI
10.1371/journal.pone.0134556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and biological analysis of benzazol-2-yl piperazine sulfonamides as 11β-hydroxysteroid dehydrogenase 1 inhibitors
- (2013) Sandra Hofer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
- (2013) Roland W. Bürli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates
- (2013) Christopher J. Millard et al. MOLECULAR CELL
- Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
- (2013) Antonino Grassadonia et al. Cancers
- Development and therapeutic impact of HDAC6-selective inhibitors
- (2012) Sabrina Dallavalle et al. BIOCHEMICAL PHARMACOLOGY
- Histone Deacetylase Inhibitors: Structure-Based Modeling and Isoform-Selectivity Prediction
- (2012) Laura Silvestri et al. Journal of Chemical Information and Modeling
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide
- (2011) J Chang et al. BRITISH JOURNAL OF CANCER
- Identification of Four Potential Epigenetic Modulators from the NCI Structural Diversity Library Using a Cell-Based Assay
- (2010) Anne M. Best et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Pyridylalanine-Containing Hydroxamic Acids as Selective HDAC6 Inhibitors
- (2008) Stefan Schäfer et al. ChemMedChem
- Histone Deacetylase Inhibitors: From Bench to Clinic
- (2008) Marielle Paris et al. JOURNAL OF MEDICINAL CHEMISTRY
- A quantitative high-throughput screen identifies potential epigenetic modulators of gene expression
- (2007) Ronald L. Johnson et al. ANALYTICAL BIOCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now